Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population
Open Access
- 2 September 2019
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2019, 1-14
Abstract
Zika virus (ZIKV), an emerging mosquito-borne flavivirus, has quickly spread in many regions around the world where dengue virus (DENV) is endemic. This represents a major health concern, given the high homology between these two viruses, which can result in cross-reactivity. The aim of this study was to determine the cross-reacting antibody response of the IgM and IgG classes against the recombinant envelope protein of ZIKV (rE-ZIKV) in sera from patients with acute-phase infection of different clinical forms of dengue, i.e., dengue fever (DF) and dengue hemorrhagic fever (DHF) (before the arrival of ZIKV in Mexico 2010), as well as acute-phase sera of ZIKV patients, together with the implications in neutralization and antibody-dependent enhancement. Differences in IgM responses were observed in a number of DF and DHF patients whose sera cross-reacted with the rE-ZIK antigen, with 42% recognition between acute-phase DHF and ZIKV but 27% recognition between DF and ZIKV. Regarding IgG antibodies, 71.5% from the DF group showed cross-reactivity to rE-ZIKV in contrast with 50% and only 25% of DHF and ZIKV serum samples, respectively, which specifically recognized the homologous antigen. The DHF group showed more enhancement of ZIKV infection of FCRγ-expressing cells compared to the DF group. Furthermore, the DHF group also showed a higher cross-neutralizing ability than that of DF. This is the first report where DF and DHF serum samples were evaluated for cross-reactivity against Zika protein and ZIKV. Furthermore, DENV serum samples cross-protect against ZIKV through neutralizing antibodies but at the same time mediate antibody-dependent enhancement in the sequential ZIKV infection.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (256235, 2015-02-1192, 2014-1-233347)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (256235, 2015-02-1192, 2014-1-233347)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (256235, 2015-02-1192, 2014-1-233347)
This publication has 45 references indexed in Scilit:
- Plasmablasts Generated during Repeated Dengue Infection Are Virus Glycoprotein–Specific and Bind to Multiple Virus SerotypesThe Journal of Immunology, 2012
- The Human Antibody Response to Dengue Virus InfectionViruses, 2011
- A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E ProteinPLOS ONE, 2011
- The Complexity of Antibody-Dependent Enhancement of Dengue Virus InfectionViruses, 2010
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing ActivityCell Host & Microbe, 2010
- A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cellsJournal of Virological Methods, 2010
- Zika Virus Outbreak on Yap Island, Federated States of MicronesiaNew England Journal of Medicine, 2009
- DNA Priming E and NS1 Constructs–Homologous Proteins Boosting Immunization Strategy to Improve Immune Response Against Dengue in MiceViral Immunology, 2005
- Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cellsInternational Journal of Experimental Pathology, 2005
- Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero CellsJournal of Virology, 2001